Keywords: Prana Biotech, PBT434, Parkinson;s disease, Development milestone

Prana Parkinson's drug meets development milestone

Article | 30 August 2012

Print This

Australia’s Prana Biotechnology (ASX: PBT) ,says that its lead compound in development for Parkinson's disease, PBT434, had progressed ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in